Arrient Healthcare Pvt Ltd
Glimepiride (3mg) + Metformin (500mg) + Voglibose (0.mg)
Glimpure MV 3.3 Tablet SR is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Glimpure MV 3.3 Tablet SR is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimpure MV 3.3 Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glimpure MV 3.3 Tablet SR.
Glimpure MV 3.3 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glimpure MV 3.3 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimpure MV 3.3 Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glimpure MV 3.3 Tablet SR is a combination medication containing Glimepiride, Metformin, and Voglibose. It is used to treat type 2 diabetes mellitus (DM) in adults, in conjunction with a healthy diet and regular exercise. Glimepiride increases insulin release from the pancreas, Metformin reduces glucose production in the liver and improves insulin sensitivity, and Voglibose lowers postprandial glucose levels. This medication is not suitable for treating type 1 DM.
Common side effects of Glimpure MV 3.3 Tablet SR include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. If you experience any of these symptoms, consult your doctor or healthcare professional.
Glimpure MV 3.3 Tablet SR should be avoided in patients with known allergies to its components or excipients. Additionally, it is contraindicated in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis.
No, it is not recommended to consume alcohol while taking Glimpure MV 3.3 Tablet SR. This may increase the risk of hypoglycemia and lactic acidosis. Consult your doctor or healthcare professional for personalized advice.
Yes, Glimpure MV 3.3 Tablet SR can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This is more likely to occur if you miss or delay meals, drink alcohol, over-exercise, or take other antidiabetic medications. Regularly monitor your blood sugar levels and keep glucose tablets, honey, or fruit juice with you.
Store Glimpure MV 3.3 Tablet SR in its original packaging, tightly closed. Follow the storage instructions provided on the packaging or label. Dispose of unused medication properly, ensuring it is not consumed by pets, children, or other individuals.